top of page
Nanite in the News

Nanite Inc. Receives Up to $2M Investment from CF Foundation to Explore a Novel Method to Deliver Genetic Therapies to the Lung
March 15, 2023

Boston  Nanite Inc. announced today an investment from the Cystic Fibrosis Foundation of up to $2 million to develop gene delivery technologies for the lung. This investment builds on the $6M seed financing recently announced by the company.

CMT Research Foundation and Nanite Inc. Announce Partnership to Enhance Therapeutic Efficacy of Antisense Oligonucleotides in CMT1A

February 22, 2023

Atlanta – The CMT Research Foundation (CMTRF), a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth (CMT) disease...

Nanite nabs $6 million to debut AI platform for polymer design

Featured in C&EN News

February 20, 2023

Boston-based startup Nanite has netted $6 million in seed funding to launch its artificial intelligence platform for gene delivery. 

Nanite Debuts AI-Driven Polymer Design Platform for Gene Delivery

February 15, 2023

Boston  Nanite Inc. announced today the closing of a $6M seed investment round to advance their AI-driven polymer design platform focused on next-generation, non-viral gene delivery.

bottom of page